Literature DB >> 10629029

Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization.

Y Nie1, H H Li, C M Bula, X Liu.   

Abstract

The carboxyl terminus of p53 is a target of a variety of signals for regulation of p53 DNA binding. Growth suppressor c-Abl interacts with p53 in response to DNA damage and overexpression of c-Abl leads to G(1) growth arrest in a p53-dependent manner. Here, we show that c-Abl binds directly to the carboxyl-terminal regulatory domain of p53 and that this interaction requires tetramerization of p53. Importantly, we demonstrate that c-Abl stimulates the DNA-binding activity of wild-type p53 but not of a carboxyl-terminally truncated p53 (p53Delta363C). A deletion mutant of c-Abl that does not bind to p53 is also incapable of activating p53 DNA binding. These data suggest that the binding to the p53 carboxyl terminus is necessary for c-Abl stimulation. To investigate the mechanism for this activation, we have also shown that c-Abl stabilizes the p53-DNA complex. These results led us to hypothesize that the interaction of c-Abl with the C terminus of p53 may stabilize the p53 tetrameric conformation, resulting in a more stable p53-DNA complex. Interestingly, the stimulation of p53 DNA-binding by c-Abl does not require its tyrosine kinase activity, indicating a kinase-independent function for c-Abl. Together, these results suggest a detailed mechanism by which c-Abl activates p53 DNA-binding via the carboxyl-terminal regulatory domain and tetramerization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10629029      PMCID: PMC85189          DOI: 10.1128/MCB.20.3.741-748.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.

Authors:  L Liu; D M Scolnick; R C Trievel; H B Zhang; R Marmorstein; T D Halazonetis; S L Berger
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

2.  Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.

Authors:  R A Van Etten; J Debnath; H Zhou; J M Casasnovas
Journal:  Oncogene       Date:  1995-05-18       Impact factor: 9.867

Review 3.  Signaling to p53: breaking the MDM2-p53 circuit.

Authors:  C Prives
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

4.  ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins.

Authors:  M J Waterman; E S Stavridi; J L Waterman; T D Halazonetis
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

5.  How p53 binds DNA as a tetramer.

Authors:  K G McLure; P W Lee
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

6.  Role for p300 in stabilization of p53 in the response to DNA damage.

Authors:  Z M Yuan; Y Huang; T Ishiko; S Nakada; T Utsugisawa; H Shioya; Y Utsugisawa; K Yokoyama; R Weichselbaum; Y Shi; D Kufe
Journal:  J Biol Chem       Date:  1999-01-22       Impact factor: 5.157

7.  Proposed mechanism for the stabilization of nuclear receptor DNA binding via protein dimerization.

Authors:  G Jiang; U Lee; F M Sladek
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

8.  Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

Authors:  W Gu; R G Roeder
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

9.  MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization.

Authors:  F M Sladek; Q Dallas-Yang; L Nepomuceno
Journal:  Diabetes       Date:  1998-06       Impact factor: 9.461

10.  Reversal of in vitro p53 squelching by both TFIIB and TFIID.

Authors:  X Liu; A J Berk
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

View more
  16 in total

1.  c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination.

Authors:  R V Sionov; S Coen; Z Goldberg; M Berger; B Bercovich; Y Ben-Neriah; A Ciechanover; Y Haupt
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.

Authors:  Kristine McKinney; Carol Prives
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

3.  Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.

Authors:  Robert D Kendig; Fumitake Kai; Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Invest       Date:  2017-04-13       Impact factor: 2.176

4.  Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation.

Authors:  Rui Kamada; Takao Nomura; Carl W Anderson; Kazuyasu Sakaguchi
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

5.  Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.

Authors:  Yutaka Maeda; Wendy W Hwang-Verslues; Gang Wei; Takuya Fukazawa; Mary L Durbin; Laurie B Owen; Xuan Liu; Frances M Sladek
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

6.  c-Abl is required for development and optimal cell proliferation in the context of p53 deficiency.

Authors:  Y E Whang; C Tran; C Henderson; R G Syljuasen; N Rozengurt; W H McBride; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

7.  Characterization of cells and gene-targeted mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1).

Authors:  Seiji Kondo; Ying Lu; Michael Debbas; Athena W Lin; Ildiko Sarosi; Annick Itie; Andrew Wakeham; JoAnn Tuan; Chris Saris; Gary Elliott; Weili Ma; Samuel Benchimol; Scott W Lowe; Tak Wah Mak; Sushil K Thukral
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

8.  Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).

Authors:  Ying Zhao; Shaoli Lu; Lipeng Wu; Guolin Chai; Haiying Wang; Yingqi Chen; Jia Sun; Yu Yu; Wen Zhou; Quanhui Zheng; Mian Wu; Gregory A Otterson; Wei-Guo Zhu
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

9.  Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation.

Authors:  Zehavit Goldberg; Ronit Vogt Sionov; Michael Berger; Yaara Zwang; Ruth Perets; Richard A Van Etten; Moshe Oren; Yoichi Taya; Ygal Haupt
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

10.  Tip60-mediated acetylation activates transcription independent apoptotic activity of Abl.

Authors:  Zhihua Jiang; Ravindra Kamath; Shunquian Jin; Manimalha Balasubramani; Tej K Pandita; Baskaran Rajasekaran
Journal:  Mol Cancer       Date:  2011-07-22       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.